Zepp Health (ZEPP) Competitors $3.05 -0.08 (-2.52%) As of 01/22/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ZEPP vs. LTRX, SILC, QMCO, INVE, ALOT, MKFG, OSS, TACT, LINK, and BOSCShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Lantronix (LTRX), Silicom (SILC), Quantum (QMCO), Identiv (INVE), AstroNova (ALOT), Markforged (MKFG), One Stop Systems (OSS), TransAct Technologies (TACT), Interlink Electronics (LINK), and B.O.S. Better Online Solutions (BOSC). These companies are all part of the "computer hardware" industry. Zepp Health vs. Lantronix Silicom Quantum Identiv AstroNova Markforged One Stop Systems TransAct Technologies Interlink Electronics B.O.S. Better Online Solutions Zepp Health (NYSE:ZEPP) and Lantronix (NASDAQ:LTRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Do insiders and institutionals have more ownership in ZEPP or LTRX? 52.6% of Zepp Health shares are held by institutional investors. Comparatively, 39.4% of Lantronix shares are held by institutional investors. 36.0% of Zepp Health shares are held by insiders. Comparatively, 1.6% of Lantronix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, ZEPP or LTRX? Lantronix has lower revenue, but higher earnings than Zepp Health. Lantronix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZepp Health$351.46M0.13-$29.88M-$2.50-1.22Lantronix$160.33M0.96-$4.52M-$0.14-28.50 Do analysts rate ZEPP or LTRX? Zepp Health currently has a consensus target price of $14.65, indicating a potential upside of 380.17%. Lantronix has a consensus target price of $6.50, indicating a potential upside of 62.91%. Given Zepp Health's higher possible upside, equities analysts clearly believe Zepp Health is more favorable than Lantronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zepp Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Lantronix 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ZEPP or LTRX more profitable? Lantronix has a net margin of -3.17% compared to Zepp Health's net margin of -19.24%. Lantronix's return on equity of -2.91% beat Zepp Health's return on equity.Company Net Margins Return on Equity Return on Assets Zepp Health-19.24% -12.03% -6.69% Lantronix -3.17%-2.91%-1.60% Does the media favor ZEPP or LTRX? In the previous week, Lantronix had 7 more articles in the media than Zepp Health. MarketBeat recorded 7 mentions for Lantronix and 0 mentions for Zepp Health. Lantronix's average media sentiment score of 0.58 beat Zepp Health's score of 0.00 indicating that Lantronix is being referred to more favorably in the news media. Company Overall Sentiment Zepp Health Neutral Lantronix Positive Does the MarketBeat Community favor ZEPP or LTRX? Lantronix received 259 more outperform votes than Zepp Health when rated by MarketBeat users. Likewise, 58.44% of users gave Lantronix an outperform vote while only 57.14% of users gave Zepp Health an outperform vote. CompanyUnderperformOutperformZepp HealthOutperform Votes457.14% Underperform Votes342.86% LantronixOutperform Votes26358.44% Underperform Votes18741.56% Which has more risk & volatility, ZEPP or LTRX? Zepp Health has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Lantronix has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. SummaryLantronix beats Zepp Health on 12 of the 17 factors compared between the two stocks. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthElectronic computers IndustryMedical SectorNYSE ExchangeMarket Cap$45.92M$434.85B$5.39B$19.96BDividend YieldN/A0.92%5.37%3.61%P/E Ratio-1.2224.9089.1141.72Price / Sales0.133.171,221.8417.35Price / CashN/A21.9243.6020.20Price / Book0.1310.805.015.73Net Income-$29.88M$12.30B$117.81M$1.01B7 Day Performance3.42%4.54%2.03%1.51%1 Month Performance8.96%5.17%4.03%5.44%1 Year Performance-49.82%21.36%26.78%18.48% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health3.0693 of 5 stars$3.05-2.5%$14.65+380.2%-49.8%$47.11M$205.23M-1.221,230Gap DownHigh Trading VolumeLTRXLantronix3.2049 of 5 stars$3.55-5.8%$6.50+83.1%-41.7%$136.59M$161.72M-25.36350Analyst ForecastSILCSilicom2.7308 of 5 stars$17.56flat$20.00+13.9%-2.8%$118.64M$62.39M-5.85320News CoveragePositive NewsQMCOQuantum0.8391 of 5 stars$20.90-23.9%$5.00-76.1%+424.2%$101.32M$285.24M0.00900Gap UpINVEIdentiv3.9421 of 5 stars$3.66+1.7%$7.25+98.1%-53.3%$87.42M$104.22M1.20330ALOTAstroNova1.6099 of 5 stars$11.36-3.3%N/A-31.6%$85.53M$153.52M13.52340News CoveragePositive NewsMKFGMarkforged3.6742 of 5 stars$3.42+2.7%$5.00+46.2%-59.6%$70.52M$86.89M-0.79370Analyst RevisionPositive NewsGap UpOSSOne Stop Systems2.5787 of 5 stars$3.10-1.9%$5.00+61.3%+108.4%$65.46M$52.71M-6.20110TACTTransAct Technologies2.9224 of 5 stars$4.49+3.2%$7.50+67.0%-41.5%$44.95M$46.42M-22.45120News CoverageLINKInterlink Electronics0.9294 of 5 stars$6.37-0.5%N/A+6.0%$41.29M$12.23M70.7890News CoverageGap UpBOSCB.O.S. Better Online Solutions3.091 of 5 stars$3.56-2.5%$5.00+40.4%+31.7%$20.51M$40.45M9.1380News CoveragePositive News Related Companies and Tools Related Companies Lantronix Alternatives Silicom Alternatives Quantum Alternatives Identiv Alternatives AstroNova Alternatives Markforged Alternatives One Stop Systems Alternatives TransAct Technologies Alternatives Interlink Electronics Alternatives B.O.S. Better Online Solutions Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ZEPP) was last updated on 1/23/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredThe #1 Stock for Trump’s Second Term?Imagine how much money you could make if you bought all of the top performing stocks during Trump's second ter...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
